BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/1/2014 8:25:00 PM | Browse: 1346 | Download: 1243
Publication Name World Journal of Gastroenterology
Manuscript ID 9722
Country Portugal
Received
2014-02-25 11:51
Peer-Review Started
2014-02-25 14:22
To Make the First Decision
2014-03-27 20:57
Return for Revision
2014-03-31 10:22
Revised
2014-04-21 00:00
Second Decision
2014-05-26 21:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-26 21:38
Articles in Press
2014-05-26 22:00
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-18 15:28
Publish the Manuscript Online
2014-10-01 20:25
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Non-alcoholic fatty liver disease: What the clinician needs to know
Manuscript Source Invited Manuscript
All Author List Mariana Verdelho Machado and Helena Cortez-Pinto
Funding Agency and Grant Number
Corresponding Author Helena Cortez-Pinto, MD, PhD, Departamento de Gastrenterologia, Laboratório de Nutrição, Hospital Universitário de Santa Maria, Lisbon 1649-035, Portugal. hlcortezpinto@netcabo.pt
Key Words Non-alcoholic fatty liver disease; Metabolic syndrome; Insulin resistance; Epidemiology; Pathogenesis; Genetics; Diagnosis; Prognosis; Management
Core Tip This is a review in non-alcoholic fatty liver disease (NAFLD) that puts the disease into context, highlights the recent advances in pathology, and gives special focus to the diagnosis and management of those patients. We present NAFLD patients in a holistic view, understanding that it many cases thinking outside the liver, namely in the cardiovascular and neoplastic risk, may have a bigger impact in the prognosis. In the era of genomics and high-throughput approaches, we also summarized the latest breakthroughs regarding the genetic associations with NAFLD.
Publish Date 2014-10-01 20:25
Citation Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: What the clinician needs to know. World J Gastroenterol 2014; 20(36): 12956-12980
URL http://www.wjgnet.com/1007-9327/full/v20/i36/12956.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i36.12956
Full Article (PDF) WJG-20-12956.pdf
Full Article (Word) WJG-20-12956.doc
Manuscript File 9722-Review.docx
Answering Reviewers 9722-Answering reviewers.pdf
Copyright License Agreement 9722-Copyright assignment.pdf
Peer-review Report 9722-Peer reviews.pdf
Scientific Misconduct Check 9722-CrossCheck.jpg
Scientific Editor Work List 9722-Scientific editor work list.pdf